Pharma Aids Limited (DSE: PHARMAID)
Bangladesh
· Delayed Price · Currency is BDT 623.20
+12.20 (2.00%)
At close: Nov 14, 2024
Pharma Aids Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 13, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Market Capitalization | 1,944 | 2,086 | 2,467 | 2,543 | 1,241 | 1,273 | Upgrade
|
| Market Cap Growth | -15.45% | -15.45% | -2.98% | 104.83% | -2.50% | -32.83% | Upgrade
|
| Enterprise Value | 1,932 | 2,039 | 2,459 | 2,502 | 1,228 | 1,278 | Upgrade
|
| Last Close Price | 623.20 | 668.50 | 789.70 | 808.82 | 391.09 | 396.52 | Upgrade
|
| PE Ratio | 28.86 | 34.09 | - | 72.59 | 24.28 | 23.58 | Upgrade
|
| PS Ratio | 4.51 | 4.95 | 8.00 | 7.87 | 4.43 | 4.72 | Upgrade
|
| PB Ratio | 5.39 | 6.08 | 8.66 | 8.25 | 4.27 | 4.94 | Upgrade
|
| P/TBV Ratio | 6.08 | 6.08 | 8.66 | 8.25 | 4.27 | 4.94 | Upgrade
|
| P/FCF Ratio | 162.90 | 92.27 | 487.65 | 87.24 | 58.77 | 35.68 | Upgrade
|
| P/OCF Ratio | 91.53 | 91.53 | 339.47 | 75.13 | 39.53 | 31.29 | Upgrade
|
| EV/Sales Ratio | 4.48 | 4.84 | 7.97 | 7.74 | 4.38 | 4.74 | Upgrade
|
| EV/EBITDA Ratio | 19.74 | 22.36 | 134.45 | 40.46 | 16.47 | 15.90 | Upgrade
|
| EV/EBIT Ratio | 21.21 | 24.20 | 230.56 | 46.32 | 18.52 | 17.80 | Upgrade
|
| EV/FCF Ratio | 161.85 | 90.22 | 485.99 | 85.84 | 58.15 | 35.82 | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.05 | 0.04 | 0.00 | 0.00 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.20 | 0.20 | 0.63 | 0.02 | 0.00 | 0.06 | Upgrade
|
| Debt / FCF Ratio | 0.80 | 0.80 | 2.27 | 0.03 | 0.01 | 0.14 | Upgrade
|
| Asset Turnover | 0.98 | 0.98 | 0.81 | 0.89 | 0.85 | 0.90 | Upgrade
|
| Inventory Turnover | 4.91 | 4.91 | 4.27 | 4.26 | 5.48 | 5.13 | Upgrade
|
| Quick Ratio | 1.36 | 1.36 | 1.77 | 2.50 | 3.47 | 3.29 | Upgrade
|
| Current Ratio | 3.06 | 3.06 | 3.26 | 4.32 | 5.17 | 4.17 | Upgrade
|
| Return on Equity (ROE) | 19.50% | 19.50% | -2.15% | 11.60% | 18.32% | 21.89% | Upgrade
|
| Return on Assets (ROA) | 12.23% | 12.23% | 1.75% | 9.35% | 12.60% | 14.93% | Upgrade
|
| Return on Capital (ROIC) | 16.03% | 16.03% | 2.20% | 11.24% | 14.97% | 17.98% | Upgrade
|
| Earnings Yield | 3.46% | 2.93% | -0.26% | 1.37% | 4.05% | 4.12% | Upgrade
|
| FCF Yield | 0.61% | 1.08% | 0.21% | 1.15% | 1.70% | 2.80% | Upgrade
|
| Dividend Yield | 0.40% | - | 0.13% | 0.62% | 1.28% | 1.26% | Upgrade
|
| Payout Ratio | 4.87% | 7.90% | - | 72.69% | 29.94% | 36.04% | Upgrade
|
| Buyback Yield / Dilution | -0.21% | -0.01% | - | - | - | - | Upgrade
|
| Total Shareholder Return | 0.19% | -0.01% | 0.13% | 0.62% | 1.28% | 1.26% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.